Fludarabine plus cyclophosphamide (FC) in patients with previously untreated low-grade lymphoma

被引：0
|
作者：
Dell'Olio, M. [1 ]
La Sala, A. [1 ]
Merla, E. [1 ]
Bodenizza, C. [1 ]
Carella, A. M. [1 ]
Falcone, A. [1 ]
Greco, M. M. [1 ]
Mantuano, S. [1 ]
Melillo, L. [1 ]
Nobile, M. [1 ]
Sanpaolo, G. [1 ]
Scalzulli, P. R. [1 ]
Cascavilla, N. [1 ]
机构：
[1] Casa Sollievo Sofferenza Hosp, IRCCS, San Giovanni Rotondo, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [1] Fludarabine plus cyclophosphamide (FC) in patients with previously untreated low-grade lymphoma
    Dell'Olio, M.
    Bodenizza, C.
    Carella, A. M.
    Falcone, A.
    Greco, M. M.
    La Sala, A.
    Mantuano, S.
    Melillo, L.
    Merla, E.
    Nobile, M.
    Sanpaolo, G.
    Scalzulli, P.
    Cascavilla, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 537 - 537
  • [2] Fludarabine: A phase II trial in patients with previously treated low-grade lymphoma
    Falkson, CI
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (03): : 268 - 270
  • [3] CPF (cyclophosphamide, prednisone, fludarabine) in advanced stage previously untreated low grade and mantle cell lymphoma.
    Klasa, R
    Connors, J
    Gascoyne, R
    Hoskins, P
    OReilly, S
    Shenkier, T
    BLOOD, 1997, 90 (10) : 1527 - 1527
  • [4] FLUDARABINE IN LOW-GRADE LYMPHOMA
    PIGADITOU, A
    ROHATINER, AZS
    WHELAN, JS
    JOHNSON, PWM
    GANJOO, RK
    ROSSI, A
    NORTON, AJA
    AMESS, J
    LIM, J
    LISTER, TA
    SEMINARS IN ONCOLOGY, 1993, 20 (05) : 24 - 27
  • [5] Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma
    Santini, G
    Nati, S
    Spriano, M
    Gallamini, A
    Pierluigi, D
    Congiu, AM
    Truini, M
    Rubagotti, A
    Chisesi, T
    Vimercati, R
    Rossi, E
    Sertoli, MR
    Mattei, D
    Marino, G
    Gobbi, M
    HAEMATOLOGICA, 2001, 86 (03) : 282 - 286
  • [6] FLUDARABINE - AN ACTIVE AGENT IN THE TREATMENT OF PREVIOUSLY-TREATED AND UNTREATED LOW-GRADE NON-HODGKINS-LYMPHOMA
    ZINZANI, PL
    LAURIA, F
    RONDELLI, D
    BENFENATI, D
    RASPADORI, D
    BOCCHIA, M
    BENDANDI, M
    GOZZETTI, A
    ZAJA, F
    FANIN, R
    RUSSO, D
    GALIENI, P
    TURA, S
    ANNALS OF ONCOLOGY, 1993, 4 (07) : 575 - 578
  • [7] Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: Results and long-term follow-up - A report from the Eastern Cooperative Oncology Group
    Hochster, HS
    Oken, MM
    Winter, JN
    Gordon, LI
    Raphael, BG
    Bennett, JM
    Cassileth, PA
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) : 987 - 994
  • [8] Rituximab is active in patients with previously untreated low-grade non-Hodgkin's lymphoma
    不详
    CLINICAL LYMPHOMA, 2001, 2 (01): : 12 - 12
  • [9] Cladribine alone or in combination with cyclophosphamide, and COP in previously untreated patients with low grade non-Hodgkin lymphoma
    Kalinka, E
    Wajs, J
    Sulek, K
    Blasinska-Morawiec, M
    Robak, T
    Holowiecki, J
    Sawczuk-Chabin, J
    Ceglarek, B
    Konopka, L
    Jedrzejczak, W
    Centkowski, P
    Warzocha, K
    ANNALS OF ONCOLOGY, 2005, 16 : 157 - 157
  • [10] Chemoimmunotherapy with ofatumumab, fludarabine, and cyclophosphamide (O-FC) in previously untreated patients with chronic lymphocytic leukemia (CLL).
    Wierda, W. G.
    Kipps, T. J.
    Duerig, J.
    Griskevicius, L.
    Stilgenbauer, S.
    Mayer, J.
    Gorczyca, M.
    Andersen, M.
    Nielsen, T.
    Russell, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345